Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kyoto iPSC-derived dopaminergic progenitor transplantation for Parkinson's disease
jRCT2090220384Completed
- Sponsor
- Kyoto University Hospital
- Start
- Sep 2018
- Countries
- 1
01
Overview
Open-label trial in Parkinson's disease (PD) (2 cohorts), sponsored by Kyoto University Hospital. Primary endpoints: Incidence and severity of adverse events and Presence or absence of graft expansion at 24 months. Started Sep 2018; status: completed.
02
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on jRCT2090220384.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2090220384.